Bruck Claudine
- SEC CIK
- 0001733680
No open-market purchases or sales filed in the past year.
Current role at each company
- ANVS Annovis Bio, Inc.Directoras of Nov 12, 2025
- NAVB Navidea Biopharmaceuticals, Inc.Directoras of Jul 7, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bruck Claudine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ANVS Annovis Bio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2021 (view filing) | Oct 11 | 2 days | Bruck ClaudineDirector | PPurchase | +181 | $27.66 | +$5.01K | +3.1%6.07K after |